Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.

Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 19;5(3):e453. doi: 10.1212/NXI.0000000000000453. eCollection 2018 May.

2.

Why monkeys do not get multiple sclerosis (spontaneously): An evolutionary approach.

Bove RM.

Evol Med Public Health. 2018 Jan 23;2018(1):43-59. doi: 10.1093/emph/eoy002. eCollection 2018. Review.

3.

Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients.

Bove R, Healy BC, Musallam A, Soltany P, Diaz-Cruz C, Sattarnezhad N, Glanz BI, Kivisäkk P, Miller KK, Chitnis T.

Mult Scler. 2018 Jan 1:1352458517750768. doi: 10.1177/1352458517750768. [Epub ahead of print]

PMID:
29320952
4.

Harnessing electronic medical records to advance research on multiple sclerosis.

Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, Baranzini SE, Cree BA, Henry RG, Hauser SL, Gelfand JM, Gourraud PA.

Mult Scler. 2018 Jan 1:1352458517747407. doi: 10.1177/1352458517747407. [Epub ahead of print]

PMID:
29310490
5.

Hormones and MS: Risk factors, biomarkers, and therapeutic targets.

Bove R, Gilmore W.

Mult Scler. 2018 Jan;24(1):17-21. doi: 10.1177/1352458517737396.

PMID:
29307303
6.

Diagnosing multiple sclerosis: art and science.

Bove RM, Hauser SL.

Lancet Neurol. 2018 Feb;17(2):109-111. doi: 10.1016/S1474-4422(17)30461-1. Epub 2017 Dec 21. No abstract available.

PMID:
29275980
7.

High risk of postpartum relapses in neuromyelitis optica spectrum disorder.

Klawiter EC, Bove R, Elsone L, Alvarez E, Borisow N, Cortez M, Mateen F, Mealy MA, Sorum J, Mutch K, Tobyne SM, Ruprecht K, Buckle G, Levy M, Wingerchuk D, Paul F, Cross AH, Jacobs A, Chitnis T, Weinshenker B.

Neurology. 2017 Nov 28;89(22):2238-2244. doi: 10.1212/WNL.0000000000004681. Epub 2017 Nov 1.

PMID:
29093070
8.

Remyelinating Pharmacotherapies in Multiple Sclerosis.

Bove RM, Green AJ.

Neurotherapeutics. 2017 Oct;14(4):894-904. doi: 10.1007/s13311-017-0577-0. Review.

PMID:
28948533
9.

SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts.

Bove R, Chitnis T, Cree BA, Tintoré M, Naegelin Y, Uitdehaag BM, Kappos L, Khoury SJ, Montalban X, Hauser SL, Weiner HL; SUMMIT Consortium.

Mult Scler. 2017 Aug 1:1352458517726657. doi: 10.1177/1352458517726657. [Epub ahead of print]

PMID:
28847219
10.

Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study.

Bove R, Elsone L, Alvarez E, Borisow N, Cortez MM, Mateen FJ, Mealy MA, Mutch K, Tobyne S, Ruprecht K, Buckle G, Levy M, Wingerchuk DM, Paul F, Cross AH, Weinshenker B, Jacob A, Klawiter EC, Chitnis T.

Neurol Neuroimmunol Neuroinflamm. 2017 Mar 24;4(3):e339. doi: 10.1212/NXI.0000000000000339. eCollection 2017 May.

11.

Oral contraceptives and MS disease activity in a contemporary real-world cohort.

Bove R, Rankin K, Chua AS, Saraceno T, Sattarnezhad N, Greeke E, Stuart F, LaRussa A, Glanz BI, Chitnis T.

Mult Scler. 2018 Feb;24(2):227-230. doi: 10.1177/1352458517692420. Epub 2017 Feb 3.

PMID:
28155573
12.

Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.

Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, Bove R, Green AJ, Nourbakhsh B, Tremblay M, Gourraud PA, Ng MY, Pletcher MJ, Olgin JE, Marcus GM, Allen DD, Cree BA, Gelfand JM.

J Neurol. 2017 Feb;264(2):316-326. doi: 10.1007/s00415-016-8334-6. Epub 2016 Nov 28.

13.

Immunology of neuromyelitis optica during pregnancy.

Davoudi V, Keyhanian K, Bove RM, Chitnis T.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 7;3(6):e288. eCollection 2016 Dec. Review.

14.

Patient Management Problem-Preferred Responses.

Bove R.

Continuum (Minneap Minn). 2016 Oct;22(5, Neuroimaging):1738-1746. No abstract available.

PMID:
27741002
15.

Patient Management Problem.

Bove R.

Continuum (Minneap Minn). 2016 Oct;22(5, Neuroimaging):1731-1737. No abstract available.

PMID:
27741001
16.

Women's experiences of menopause in an online MS cohort: A case series.

Bove R, Vaughan T, Chitnis T, Wicks P, De Jager PL.

Mult Scler Relat Disord. 2016 Sep;9:56-9. doi: 10.1016/j.msard.2016.06.015. Epub 2016 Jul 1.

17.

Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis.

Bove R, White CC, Fitzgerald KC, Chitnis T, Chibnik L, Ascherio A, Munger KL.

Neurology. 2016 Oct 4;87(14):1457-1463. Epub 2016 Sep 7.

18.

Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset.

Bove R, Chua AS, Xia Z, Chibnik L, De Jager PL, Chitnis T.

Neurol Genet. 2016 Jul 26;2(4):e88. doi: 10.1212/NXG.0000000000000088. eCollection 2016 Aug.

19.

Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity.

Bove R, Musallam A, Xia Z, Baruch N, Messina S, Healy BC, Chitnis T.

Mult Scler Relat Disord. 2016 Jul;8:136-40. doi: 10.1016/j.msard.2016.05.019. Epub 2016 May 31.

PMID:
27456889
20.

Women's Issues in Multiple Sclerosis.

Bove R.

Semin Neurol. 2016 Apr;36(2):154-62. doi: 10.1055/s-0036-1579736. Epub 2016 Apr 26.

PMID:
27116722
21.

Adolescence, imperceptible boundary between normality and pathology: a literature review.

Bove D, Bove RM, Caccavale S, Bravaccio C, Marino M, La Montagna M.

Minerva Pediatr. 2016 Apr;68(2):148-51. Review.

PMID:
27002489
22.

Ataxia telangiectasia, Menkes kinky hair disease and neurocutaneous melanosis.

Caccavale S, Bove D, Bove RM, LA Montagna M.

G Ital Dermatol Venereol. 2017 Feb;152(1):58-65. doi: 10.23736/S0392-0488.16.05083-5. Epub 2016 Mar 22. Review.

PMID:
27002302
23.

Association between adiposity and cognitive function in young men: Hormonal mechanisms.

Bove RM, Gerweck AV, Mancuso SM, Bredella MA, Sherman JC, Miller KK.

Obesity (Silver Spring). 2016 Apr;24(4):954-61. doi: 10.1002/oby.21415. Epub 2016 Feb 16.

24.

Multiple sclerosis in men: management considerations.

Bove R, McHenry A, Hellwig K, Houtchens M, Razaz N, Smyth P, Tremlett H, Sadovnick AD, Rintell D.

J Neurol. 2016 Jul;263(7):1263-73. doi: 10.1007/s00415-015-8005-z. Epub 2016 Jan 2. Review.

PMID:
26725085
25.

Effect of growth hormone on cognitive function in young women with abdominal obesity.

Bove RM, White CC, Gerweck AV, Mancuso SM, Bredella MA, Sherman JC, Miller KK.

Clin Endocrinol (Oxf). 2016 Apr;84(4):635-7. doi: 10.1111/cen.12996. Epub 2016 Feb 2. No abstract available.

26.

Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.

Bove R, White CC, Giovannoni G, Glanz B, Golubchikov V, Hujol J, Jennings C, Langdon D, Lee M, Legedza A, Paskavitz J, Prasad S, Richert J, Robbins A, Roberts S, Weiner H, Ramachandran R, Botfield M, De Jager PL.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 15;2(6):e162. doi: 10.1212/NXI.0000000000000162. eCollection 2015 Dec.

27.

Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.

Bove R, Healy BC, Musallam A, Glanz BI, De Jager PL, Chitnis T.

Mult Scler. 2016 Jun;22(7):935-43. doi: 10.1177/1352458515606211. Epub 2015 Oct 7.

28.

The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.

Bove R, Malik MT, Diaz-Cruz C, Chua A, Saraceno TJ, Bargiela D, Greeke E, Glanz BI, Healy BC, Chitnis T.

Neurology. 2015 Oct 6;85(14):1209-13. doi: 10.1212/WNL.0000000000001990. Epub 2015 Sep 4.

29.

Skin and brain: itch and psychiatric disorders.

Caccavale S, Bove D, Bove RM, LA Montagna M.

G Ital Dermatol Venereol. 2016 Oct;151(5):525-9. Epub 2015 Apr 9. Review.

PMID:
25854671
30.

Patients report worse MS symptoms after menopause: findings from an online cohort.

Bove R, Healy BC, Secor E, Vaughan T, Katic B, Chitnis T, Wicks P, De Jager PL.

Mult Scler Relat Disord. 2015 Jan;4(1):18-24. doi: 10.1016/j.msard.2014.11.009. Epub 2014 Dec 9.

PMID:
25787049
31.

Adolescence: psychopathological discomfort, distress or psychiatric disorder? Clinical experience, description and analysis of a sample.

Bove D, Bove RM, Caccavale S, Bravaccio C, LA Montagna M.

Minerva Pediatr. 2017 Apr;69(2):87-94. doi: 10.23736/S0026-4946.16.04228-6. Epub 2014 Dec 12.

PMID:
25502734
32.

Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review.

Bove R, Alwan S, Friedman JM, Hellwig K, Houtchens M, Koren G, Lu E, McElrath TF, Smyth P, Tremlett H, Sadovnick AD.

Obstet Gynecol. 2014 Dec;124(6):1157-68. doi: 10.1097/AOG.0000000000000541. Review.

PMID:
25415167
33.

An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.

Bakshi R, Neema M, Tauhid S, Healy BC, Glanz BI, Kim G, Miller J, Berkowitz JL, Bove R, Houtchens MK, Severson C, Stankiewicz JM, Stazzone L, Chitnis T, Guttmann CR, Weiner HL, Ceccarelli A.

Neuroreport. 2014 Oct 1;25(14):1156-61. doi: 10.1097/WNR.0000000000000244.

34.

Low testosterone is associated with disability in men with multiple sclerosis.

Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R, Weiner H, De Jager PL, Miller KK, Chitnis T.

Mult Scler. 2014 Oct;20(12):1584-92. doi: 10.1177/1352458514527864. Epub 2014 Apr 7.

35.

The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis.

Bove R, Chitnis T.

Mult Scler. 2014 Apr;20(5):520-6. doi: 10.1177/1352458513519181. Epub 2014 Feb 21. Review.

PMID:
24561324
36.

Patient management problem.

Bove RM.

Continuum (Minneap Minn). 2014 Feb;20(1 Neurology of Pregnancy):230-4, 235-44. doi: 10.1212/01.CON.0000443852.01923.08. Review. No abstract available.

PMID:
24492825
37.

Neuroradiology in women of childbearing age.

Bove RM, Klein JP.

Continuum (Minneap Minn). 2014 Feb;20(1 Neurology of Pregnancy):23-41. doi: 10.1212/01.CON.0000443835.10508.2b. Review.

PMID:
24492809
38.

Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women.

Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA, De Jager PL.

Neurology. 2014 Jan 21;82(3):222-9. doi: 10.1212/WNL.0000000000000033. Epub 2013 Dec 11.

39.

Modeling disease severity in multiple sclerosis using electronic health records.

Xia Z, Secor E, Chibnik LB, Bove RM, Cheng S, Chitnis T, Cagan A, Gainer VS, Chen PJ, Liao KP, Shaw SY, Ananthakrishnan AN, Szolovits P, Weiner HL, Karlson EW, Murphy SN, Savova GK, Cai T, Churchill SE, Plenge RM, Kohane IS, De Jager PL.

PLoS One. 2013 Nov 11;8(11):e78927. doi: 10.1371/journal.pone.0078927. eCollection 2013.

40.

Increased leptin and A-FABP levels in relapsing and progressive forms of MS.

Messina S, Vargas-Lowy D, Musallam A, Healy BC, Kivisakk P, Gandhi R, Bove R, Gholipour T, Khoury S, Weiner HL, Chitnis T.

BMC Neurol. 2013 Nov 11;13:172. doi: 10.1186/1471-2377-13-172.

41.

Menopause in multiple sclerosis: therapeutic considerations.

Bove R, Chitnis T, Houtchens M.

J Neurol. 2014 Jul;261(7):1257-68. doi: 10.1007/s00415-013-7131-8. Epub 2013 Oct 8. Review.

PMID:
24101131
42.

No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50.

Bove R, Musallam A, Healy BC, Houtchens M, Glanz BI, Khoury S, Guttmann CR, De Jager PL, Chitnis T.

BMC Neurol. 2013 Jul 3;13:73. doi: 10.1186/1471-2377-13-73.

43.

The effect of dopamine agonists on cognitive functions in non-demented early-mild Parkinson's disease patients.

Brusa L, Pavino V, Massimetti MC, Bove R, Iani C, Stanzione P.

Funct Neurol. 2013 Jan-Mar;28(1):13-7.

44.

Metabolic and endocrine correlates of cognitive function in healthy young women.

Bove RM, Brick DJ, Healy BC, Mancuso SM, Gerweck AV, Bredella MA, Sherman JC, Miller KK.

Obesity (Silver Spring). 2013 Jul;21(7):1343-9. doi: 10.1002/oby.20212. Epub 2013 May 13.

45.

Sexual disparities in the incidence and course of MS.

Bove R, Chitnis T.

Clin Immunol. 2013 Nov;149(2):201-10. doi: 10.1016/j.clim.2013.03.005. Epub 2013 Mar 22. Review.

PMID:
23608496
46.

Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course.

Bove R, Secor E, Healy BC, Musallam A, Vaughan T, Glanz BI, Greeke E, Weiner HL, Chitnis T, Wicks P, De Jager PL.

PLoS One. 2013;8(3):e59707. doi: 10.1371/journal.pone.0059707. Epub 2013 Mar 20.

47.

Autoimmune diseases and reproductive aging.

Bove R.

Clin Immunol. 2013 Nov;149(2):251-64. doi: 10.1016/j.clim.2013.02.010. Epub 2013 Feb 28. Review.

48.

Polygyny and women's health in rural Mali.

Bove RM, Vala-Haynes E, Valeggia C.

J Biosoc Sci. 2014 Jan;46(1):66-89. doi: 10.1017/S0021932013000059. Epub 2013 Mar 12.

49.

Multiple myeloma and paget disease with abnormal skull lesions and intracranial hypertension.

Caravita T, Siniscalchi A, Montinaro E, Bove R, Zaccagnini M, De Pascalis D, Morocutti A, Brusa L, Arciprete F, Cupini M, Perrotti A, Palma E, Fratoni S, De Simone R, Iani C, de Fabritiis P.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012068. doi: 10.4084/MJHID.2012.068. Epub 2012 Nov 5.

50.

Relapsing course of immunoglobulin G4-related pachymeningitis.

Shapiro KA, Bové RM, Volpicelli ER, Mallery RM, Stone JH.

Neurology. 2012 Aug 7;79(6):604-6. doi: 10.1212/WNL.0b013e31826356fc. Epub 2012 Jul 25. No abstract available.

PMID:
22843267

Supplemental Content

Support Center